Clinical Trial Update: Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concomitant chemoradiotherapy with weekly docetaxel and cisplatin for locally advanced head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Samsung Medical Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED